Viewing StudyNCT03250377



Ignite Creation Date: 2024-05-06 @ 10:25 AM
Last Modification Date: 2024-10-26 @ 12:29 PM
Study NCT ID: NCT03250377
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2024-05-31
First Post: 2017-07-31

Brief Title: A Study to Test the Safety Efficacy of Brivaracetam BRV Used as Adjunctive Treatment in Subjects 16 Years of Age With Partial Seizures With or Without Secondary Generalization
Sponsor: UCB Biopharma SRL
Organization: UCB Pharma

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-08-05
Start Date Type: ACTUAL
Primary Completion Date: 2025-03-03
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-03-03
Completion Date Type: ESTIMATED
First Submit Date: 2017-07-31
First Submit QC Date: August 10 2017
Study First Post Date: 2017-08-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-17
Last Update Post Date: 2024-05-31
Last Update Post Date Type: ACTUAL